Title : Epigenetics in drug development: Unlocking novel therapeutic strategies for precision medicine
Abstract:
Epigenetics, the study of heritable changes in gene expression that do not involve alterations to the DNA sequence, has revolutionized our understanding of complex biological processes and disease mechanisms. In drug development, epigenetics offers promising avenues for identifying novel therapeutic targets, personalizing treatment strategies, and improving drug efficacy and safety. Epigenetic mechanisms, such as DNA methylation, histone modifications, and non-coding RNA regulation, play critical roles in modulating gene activity and are often dysregulated in diseases, including cancer, autoimmune disorders, and neurological conditions. Drugs targeting epigenetic enzymes, such as DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), have already shown success, with several epigenetic drugs approved for clinical use in oncology. Additionally, advances in epigenomics and next-generation sequencing enable the identification of disease-specific epigenetic signatures, facilitating the development of biomarkers for early diagnosis, prognosis, and treatment response prediction. Moreover, the reversibility of epigenetic modifications presents a unique opportunity to design drugs capable of restoring normal gene expression patterns. Despite its potential, challenges such as off-target effects, limited tissue specificity, and the need for comprehensive understanding of epigenetic networks must be addressed. This review highlights recent progress in the field, discusses innovative technologies driving epigenetics-based drug discovery, and explores future directions to harness the full potential of epigenetics in precision medicine. This paradigm shift underscores the transformative role of epigenetics in bridging the gap between molecular insights and therapeutic advancements, paving the way for more effective and individualized treatment options.
Keywords: Epigenetics, Drug Development, DNA Methylation, Histone Modifications, Non-coding RNA, Epigenetic Enzymes, Biomarkers, Precision Medicine, Targeted Therapy, Epigenomics
